Global Nucleic Acid Amplification Testing (NAAT) Market Size study, by Technique (Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems), by Application (Infectious Disease, Cancer, Others) and Regional Forecasts 2020-2027

  • Report Code : BIZ2300847
  • Published On: Feb, 2021
  • Category : Diagnostics
  • Pages : 200
  • Global Nucleic Acid Amplification Testing (NAAT) Market is valued at approximately USD 2.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.4% over the forecast period 2020-2027. Nucleic Acid Amplification Test (NAAT) is an innovative technique used for the identification of a specific nucleic acid, bacteria, or virus, that act as a disease-causing pathogen from biologic samples, such as urine, tissues. etc. Furthermore, this technique is often utilized for blood screening donations to mitigate the risk of transfusion-transmitted infections in the recipients. Besides, nucleic acid amplification test is the precise detection technique used for most of the infectious agents, as it helps diagnose and improve patients care in high-income countries. Thus, it is extensively adopted over conventional diagnostic techniques for treating and curing infectious diseases, such as HIV and Ebola. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, nearly 1.7 million individuals were newly affected by HIV , compared to a 2.8 million adult population in 1998. Thus, the rise in prevalence of HIV diseases throughout the world will foster the adoption for NAAT in the forthcoming period. Along with infectious diseases, NAAT is being extensively used across numerous other fields, including cancer, personalized medicine, and forensics. This is likely to spur the adoption & utility for NAAT during the forecast period. In addition, the rise in expenditure or investment in pharmaceutical and biopharmaceutical sector, along with escalating demand for the advanced diagnostic measure are the few factors responsible for the high CAGR of the market during the forecast period. For instance, the Association of the British Pharmaceutical Industry (ABPI) estimated that the biopharmaceutical companies worldwide spent around USD 156.7 billion on R&D activities in 2016, representing an increase from USD 148 billion in 2015. Further , it is likely to grow around USD 181 billion by the year 2022. This, in turn, is likely to strengthen the demand for nucleic acid amplification testing (NAAT), thereby contributing to the market growth around the world. However, the high cost of test and shortage of skilled professionals are the major factors restraining the market growth over the forecast period 2020-2027.

    The regional analysis of the global Nucleic Acid Amplification Testing (NAAT) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to implement Nucleic Acid Amplification Testing (NAAT), along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of life-threatening diseases and infectious diseases and rising adoption of innovative diagnostic technologies in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Nucleic Acid Amplification Testing (NAAT) market in the Asia-Pacific region.

    Major market player included in this report are:

    Abbott Laboratories

    Becton, Dickinson and Company

    BioMérieux S.A.

    Bio-Rad Laboratories, Inc.

    Grifols, S.A.

    F. Hoffmann-La Roche AG

    Hologic, Inc.

    Illumina, Inc.

    Beckman Coulter, Inc.

    Siemens Healthcare GmbH

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Technique:

    Target Amplification Systems

    Probe Amplification Systems

    Signal Amplification Systems

    By Application:

    Infectious Disease

    Cancer

    Others

    By Region:

    North America

    U.S.

    Canada

    Europe

    UK

    Germany

    France

    Spain

    Italy

    ROE

    Asia Pacific

    China

    India

    Japan

    Australia

    South Korea

    RoAPAC

    Latin America

    Brazil

    Mexico

    Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2017, 2018

    Base year – 2019

    Forecast period – 2020 to 2027

    Target Audience of the Global Nucleic Acid Amplification Testing (NAAT) Market in Market Study:

    Key Consulting Companies & Advisors

    Large, medium-sized, and small enterprises

    Venture capitalists

    Value-Added Resellers (VARs)

    Third-party knowledge providers

    Investment bankers

    Investors

     

  • With tables and figures helping analyze worldwide Global Nucleic Acid Amplification Testing (NAAT) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Chapter 1. Executive Summary
    1.1. Market Snapshot
    1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    1.2.1. Nucleic Acid Amplification Testing (NAAT) Market, by Region, 2018-2027 (USD Billion)
    1.2.2. Nucleic Acid Amplification Testing (NAAT) Market, by Technique, 2018-2027 (USD Billion)
    1.2.3. Nucleic Acid Amplification Testing (NAAT) Market, by Application, 2018-2027 (USD Billion)
    1.3. Key Trends
    1.4. Estimation Methodology
    1.5. Research Assumption
    Chapter 2. Global Nucleic Acid Amplification Testing (NAAT) Market Definition and Scope
    2.1. Objective of the Study
    2.2. Market Definition & Scope
    2.2.1. Scope of the Study
    2.2.2. Industry Evolution
    2.3. Years Considered for the Study
    2.4. Currency Conversion Rates
    Chapter 3. Global Nucleic Acid Amplification Testing (NAAT) Market Dynamics
    3.1. Nucleic Acid Amplification Testing (NAAT) Market Impact Analysis (2018-2027)
    3.1.1. Market Drivers
    3.1.2. Market Challenges
    3.1.3. Market Opportunities
    Chapter 4. Global Nucleic Acid Amplification Testing (NAAT) Market Industry Analysis
    4.1. Porter’s 5 Force Model
    4.1.1. Bargaining Power of Suppliers
    4.1.2. Bargaining Power of Buyers
    4.1.3. Threat of New Entrants
    4.1.4. Threat of Substitutes
    4.1.5. Competitive Rivalry
    4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
    4.2. PEST Analysis
    4.2.1. Political
    4.2.2. Economical
    4.2.3. Social
    4.2.4. Technological
    4.3. Investment Adoption Model
    4.4. Analyst Recommendation & Conclusion
    Chapter 5. Global Nucleic Acid Amplification Testing (NAAT) Market, by Technique
    5.1. Market Snapshot
    5.2. Global Nucleic Acid Amplification Testing (NAAT) Market by Technique, Performance - Potential Analysis
    5.3. Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
    5.4. Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
    5.4.1. Target Amplification Systems
    5.4.2. Probe Amplification Systems
    5.4.3. Signal Amplification Systems
    Chapter 6. Global Nucleic Acid Amplification Testing (NAAT) Market, by Application
    6.1. Market Snapshot
    6.2. Global Nucleic Acid Amplification Testing (NAAT) Market by Application, Performance - Potential Analysis
    6.3. Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
    6.4. Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
    6.4.1. Infectious Disease
    6.4.2. Cancer
    6.4.3. Others
    Chapter 7. Global Nucleic Acid Amplification Testing (NAAT) Market, Regional Analysis
    7.1. Nucleic Acid Amplification Testing (NAAT) Market, Regional Market Snapshot
    7.2. North America Nucleic Acid Amplification Testing (NAAT) Market
    7.2.1. U.S. Nucleic Acid Amplification Testing (NAAT) Market
    7.2.1.1. Technique breakdown estimates & forecasts, 2017-2027
    7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
    7.2.2. Canada Nucleic Acid Amplification Testing (NAAT) Market
    7.3. Europe Nucleic Acid Amplification Testing (NAAT) Market Snapshot
    7.3.1. U.K. Nucleic Acid Amplification Testing (NAAT) Market
    7.3.2. Germany Nucleic Acid Amplification Testing (NAAT) Market
    7.3.3. France Nucleic Acid Amplification Testing (NAAT) Market
    7.3.4. Spain Nucleic Acid Amplification Testing (NAAT) Market
    7.3.5. Italy Nucleic Acid Amplification Testing (NAAT) Market
    7.3.6. Rest of Europe Nucleic Acid Amplification Testing (NAAT) Market
    7.4. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market Snapshot
    7.4.1. China Nucleic Acid Amplification Testing (NAAT) Market
    7.4.2. India Nucleic Acid Amplification Testing (NAAT) Market
    7.4.3. Japan Nucleic Acid Amplification Testing (NAAT) Market
    7.4.4. Australia Nucleic Acid Amplification Testing (NAAT) Market
    7.4.5. South Korea Nucleic Acid Amplification Testing (NAAT) Market
    7.4.6. Rest of Asia Pacific Nucleic Acid Amplification Testing (NAAT) Market
    7.5. Latin America Nucleic Acid Amplification Testing (NAAT) Market Snapshot
    7.5.1. Brazil Nucleic Acid Amplification Testing (NAAT) Market
    7.5.2. Mexico Nucleic Acid Amplification Testing (NAAT) Market
    7.6. Rest of The World Nucleic Acid Amplification Testing (NAAT) Market
    Chapter 8. Competitive Intelligence
    8.1. Top Market Strategies
    8.2. Company Profiles
    8.2.1. Abbott Laboratories
    8.2.1.1. Key Information
    8.2.1.2. Overview
    8.2.1.3. Financial (Subject to Data Availability)
    8.2.1.4. Product Summary
    8.2.1.5. Recent Developments
    8.2.2. Becton, Dickinson and Company
    8.2.3. BioMérieux S.A.
    8.2.4. Bio-Rad Laboratories, Inc.
    8.2.5. Grifols, S.A.
    8.2.6. F. Hoffmann-La Roche AG
    8.2.7. Hologic, Inc.
    8.2.8. Illumina, Inc.
    8.2.9. Beckman Coulter, Inc.
    8.2.10. Siemens Healthcare GmbH
    Chapter 9. Research Process
    9.1. Research Process
    9.1.1. Data Mining
    9.1.2. Analysis
    9.1.3. Market Estimation
    9.1.4. Validation
    9.1.5. Publishing
    9.2. Research Attributes
    9.3. Research Assumption

     

  • The Global Nucleic Acid Amplification Testing (NAAT) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          How are the major players in the Global Nucleic Acid Amplification Testing (NAAT) Market planning to grow in the future?

          A large number of Global Global Nucleic Acid Amplification Testing (NAAT) players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.

          What is the market value of the Global Nucleic Acid Amplification Testing (NAAT) Industry?

          In 2023, the Global Nucleic Acid Amplification Testing (NAAT) Market share exceeded USD xx million. Between 2024 and 2029, it will grow at a CAGR of yy%.

          What is really changing the Global Nucleic Acid Amplification Testing (NAAT) Market behavior?

          Consumer behavior changes will reshape the entire decision-making process and companies in the Global Nucleic Acid Amplification Testing (NAAT) Industry will need to adapt quickly.

          What is the estimated global market value of the Global Nucleic Acid Amplification Testing (NAAT) Market?

          The Global Nucleic Acid Amplification Testing (NAAT) Market is expected to reach a considerable market valuation.

          Licensing options
          USD

          Need assistance ?

          Related reports

          Our Clients